Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Christina Glöckel"'
Autor:
Wolfgang Sommergruber, Michael Freissmuth, Christina Glöckel, Simon Keuerleber, Tilman Voss, Stefan Kastner
PDF file - 62K, Gpr19 siRNA-induced increase in the relative number of DMS 53 cells with G2/M DNA content
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cccdafb01f64a90a75b0db3123094e0
https://doi.org/10.1158/1541-7786.22517430.v1
https://doi.org/10.1158/1541-7786.22517430.v1
Autor:
Wolfgang Sommergruber, Michael Freissmuth, Christina Glöckel, Simon Keuerleber, Tilman Voss, Stefan Kastner
PDF file - 51K, Detailed cell line information for human NSCLC, SCLC, and normal lung cell lines and HEK-293 cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e854bf5a69b761df23e9b90d888487e
https://doi.org/10.1158/1541-7786.22517421.v1
https://doi.org/10.1158/1541-7786.22517421.v1
Autor:
Wolfgang Sommergruber, Michael Freissmuth, Christina Glöckel, Simon Keuerleber, Tilman Voss, Stefan Kastner
PDF file - 337K, Reduced cellular proliferation upon Gpr19 siRNA treatment. Thumbnail visualization of confluence measurement for NCI-H1703 cells and phase contrast microscopy pictures of NCI-H1703 and DMS 53 cells subject to siRNA transfection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7712a2662614070f33c04bc931757248
https://doi.org/10.1158/1541-7786.22517433.v1
https://doi.org/10.1158/1541-7786.22517433.v1
Autor:
Wolfgang Sommergruber, Michael Freissmuth, Christina Glöckel, Simon Keuerleber, Tilman Voss, Stefan Kastner
PDF file - 45K, Information about TaqMan assays used in RT-qPCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41996c2587507c1836ded729b48a29eb
https://doi.org/10.1158/1541-7786.22517418
https://doi.org/10.1158/1541-7786.22517418
Autor:
Wolfgang Sommergruber, Michael Freissmuth, Christina Glöckel, Simon Keuerleber, Tilman Voss, Stefan Kastner
PDF file - 88K, Gpr19 siRNA-induced increase in binucleated and polylobed nuclei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a46ccd7f04d093ced7b63293ac8e8ae
https://doi.org/10.1158/1541-7786.22517427.v1
https://doi.org/10.1158/1541-7786.22517427.v1
Autor:
Wolfgang Sommergruber, Michael Freissmuth, Christina Glöckel, Simon Keuerleber, Tilman Voss, Stefan Kastner
PDF file - 74K, Binding of E2F1-4 to the promoter of Gpr19. The result of chromatin immunoprecipitation is shown (full size agarose gel).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::692b1e1520a02742adbc76d9a8651929
https://doi.org/10.1158/1541-7786.22517424.v1
https://doi.org/10.1158/1541-7786.22517424.v1
Autor:
Wolfgang Sommergruber, Michael Freissmuth, Christina Glöckel, Simon Keuerleber, Tilman Voss, Stefan Kastner
PDF file - 253K, Detailed patient information for NSCLC, SCLC and normal lung RNA samples from Origene Technologies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::403d9736a799e71321bf6eb2c246afc4
https://doi.org/10.1158/1541-7786.22517415
https://doi.org/10.1158/1541-7786.22517415
Autor:
Simon Keuerleber, Stefan Kastner, Christina Glöckel, Tilman Voss, Michael Freissmuth, Wolfgang Sommergruber
Publikováno v:
Molecular cancer research : MCR. 10(10)
It has long been known that G protein-coupled receptors (GPCR) are subject to illegitimate expression in tumor cells. Presumably, hijacking the normal physiologic functions of GPCRs contributes to all biologic capabilities acquired during tumorigenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63c67ce5338dec966f09c5b47783cead
https://pubmed.ncbi.nlm.nih.gov/22912338
https://pubmed.ncbi.nlm.nih.gov/22912338
Publikováno v:
BMC Pharmacology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbca8579a897d6a7789fa1f7b6138048
https://doi.org/10.1186/1471-2210-9-s2-a30
https://doi.org/10.1186/1471-2210-9-s2-a30
Publikováno v:
BMC Pharmacology
Background Selective serotonin reuptake inhibitors (SSRIs) have been observed to drive programmed cell death in Burkitt lymphoma cells. Accordingly, they were proposed as a new modality in the treatment of Burkitt lymphoma. However, they induce apopt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b726b0fb13fe7aa804d9e6a0b8b93bc